ATP6V1G1P6

Across TCGA pan-cancer cohorts, ATP6V1G1P6 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated ATP6V1G1P6 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher ATP6V1G1P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ATP6V1G1P6 expression acts as an unfavorable survival marker, although some lineages such as ESCA and STAD show a favorable association.

COAD, CESC, and LUSC are the cancer types where ATP6V1G1P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	III,IV	0.281	0.713	.001	57	view →
CESC	OS	Tertile	IV	0.121	0.591	.029	36	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
BLCA	OS	Tertile	III,IV	0.090	0.582	<.001	18	view →
KIRC	DFS	Tertile	II,III,IV	0.640	0.771	.023	18	view →
ESCA	OS	Tertile	IV	0.743	0.319	.017	18	view →
STAD	OS	Quartile	All	0.769	0.609	.013	12	view →
THYM	DFS	Tertile	All	0.646	0.934	.001	12	view →
LIHC	OS	Tertile	III,IV	0.168	0.554	.032	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

ATP6V1G1P6–COAD (OS)

Open the COAD breakdown →